SCHEMBL5804215

SCHEMBL5804215

COC(=O)C=Cc1ccc2[nH]c3c(c2c1)CCCC3

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 8/20 0.51
▸ KDM4E B2RXH2 7/20 0.51
▸ ALDH1A1 P00352 6/20 0.51
▸ SMN1; SMN2 Q16637 4/20 0.51
▸ LMNA P02545 3/20 0.51
▸ MEN1 O00255 5/20 0.51
▸ KMT2A Q03164 5/20 0.51
▸ NPC1 O15118 1/20 0.51
▸ RAB9A P51151 1/20 0.51
▸ THRB P10828 3/20 0.48
▸ TP53 P04637 3/20 0.47
▸ CASP1 P29466 2/20 0.47
▸ TTR P02766 1/20 0.47
▸ APP P05067 1/20 0.47
▸ CCNB2 O95067 1/20 0.46
▸ CDK1 P06493 1/20 0.46
▸ CCNB1 P14635 1/20 0.46
▸ GSK3B P49841 1/20 0.46
▸ CDK5 Q00535 1/20 0.46
▸ CDK5R1 Q15078 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5804213 1.00 MAPT (0.51) MAPTKDM4EALDH1A1SMN1; SMN2LMNA
SCHEMBL6924873 0.76 MAPT (0.56) MAPTKDM4EALDH1A1SMN1; SMN2LMNA
SCHEMBL30523171 0.76 MEN1 (0.74) MAPTKDM4EALDH1A1SMN1; SMN2LMNA
SCHEMBL1071505 0.76 KIF11 (0.55) MAPTKDM4EALDH1A1SMN1; SMN2LMNA
SCHEMBL12408499 0.76 KIF11 (0.55) MAPTKDM4EALDH1A1SMN1; SMN2LMNA
SCHEMBL30440640 0.76 KIF11 (0.55) MAPTKDM4EALDH1A1SMN1; SMN2LMNA
SCHEMBL4024926 0.76 MEN1 (0.74) MAPTKDM4EALDH1A1SMN1; SMN2LMNA
SCHEMBL6137514 0.75 TTR (0.46) MAPTKDM4EALDH1A1SMN1; SMN2TTR
SCHEMBL6070704 0.75 TTR (0.46) MAPTKDM4EALDH1A1SMN1; SMN2TTR
SCHEMBL16595932 0.72 TTR (0.58) MAPTKDM4EALDH1A1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006101456-A1 BICYCLIC HETEROCYCLES HYDROXAMATE COMPOUNDS USEFUL AS HISTONE DEACETYLASE (HDAC) INHIBITORS S*BIO PTE LTD (SG) 2006-09-28 — — WO disclosed
Send feedback